1993
DOI: 10.1016/0735-1097(93)90676-r
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically III patients

Abstract: Intraaortic balloon pumping unequivocally and significantly augments proximal coronary blood flow velocity, nearly doubling the coronary flow velocity integral in most patients. This mechanism may be a significant means of ischemia relief in hypotensive patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
68
0
5

Year Published

1994
1994
2017
2017

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 180 publications
(75 citation statements)
references
References 29 publications
2
68
0
5
Order By: Relevance
“…In a later study, 20 78% of surgical patients tolerated this timing method; 22% required conventional deflation. Kern et al 8 reported similar results and found that coronary blood flow increased as a result of the prolonged inflation.…”
Section: Real-time Timingsupporting
confidence: 69%
See 3 more Smart Citations
“…In a later study, 20 78% of surgical patients tolerated this timing method; 22% required conventional deflation. Kern et al 8 reported similar results and found that coronary blood flow increased as a result of the prolonged inflation.…”
Section: Real-time Timingsupporting
confidence: 69%
“…In contrast, real-time timing allows deflation to occur during the preejection phase or during early systolic ejection and may increase stroke volume because of active deflation during systolic ejection. 3,8,15,16 …”
Section: Methods and Principlesmentioning
confidence: 99%
See 2 more Smart Citations
“…8 EECP treatment is associated with an immediate increase in blood flow in multiple vascular beds including the coronary arterial circulation. 7 This increase in blood flow may result in increased endothelial shear stress, 16 which enhances endothelial function by stimulating the release of the vasodilatory mediator nitric oxide and reduces the release of the vasocontractile endothelin-1. 15,[17][18][19] However, most of the experience is from small animal or human uncontrolled studies, and the mechanism of the sustained antianginal benefit with EECP remains unclear.…”
mentioning
confidence: 99%